-
UND med school's biennial report says residents generally healthy, but birth rates continue decline
07 Feb 2025 00:11 GMT
GRAND FORKS — The UND School of Medicine & Health Sciences'
Eighth Biennial Report on Health Issues for the State of North Dakota
revealed that North Dakotans are relatively healthier than residents of other states, however, they experience a …
-
‘FoodBabe’ Tells Schweizer: These Two Massive Companies Will Push Back Hardest Against RFK Jr’s FDA
06 Feb 2025 22:28 GMT
… of the Food and Drug Administration (FDA) by lobbyists for Big … four different medications to control my asthma, three different medications to control … Senate), which includes the FDA, because she has seen … take my kids off the meds?”
For more from Peter …
-
Development of Multipayer Claims-Based Emergency Department Episodes of Care
06 Feb 2025 21:59 GMT
… episodes of care were developed by 2 statewide collaborative … among younger patients, including asthma, diabetes short-term complications, … better consensus on ideal treatment pathways for patients presenting … stakeholder perspectives. J Emerg Med. 2014;47(3): …
-
Rapid trials prompt deals rush for Chinese ‘super me-too’ drugs
06 Feb 2025 15:23 GMT
… the rights to develop and sell Chinese drugs outside the … asthma drugmaker that was sold to GSK for up to $1.4bn.
Trials … gene therapies, antibody drug conjugates and treatments created by companies … experiment with developing a wide range of drugs to see …
-
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
06 Feb 2025 08:13 GMT
… decision to initiate a systemic medication can be difficult owing … 14 Two Phase 3 clinical trials (TRuE-AD1 and TRuE- … versus vehicle (no active drug).16,17 Post-marketing analyses … for the treatment of allergic disease. Ann Allergy Asthma Immunol. 2018 …
-
China NMPA clears Harbour BioMed's IND application for HBM9378/SKB378 for chronic obstructive pulmonary disease treatment
06 Feb 2025 08:00 GMT
… has approved the Investigational New Drug (IND) application for HBM9378… the treatment of moderate-to-severe asthma. A phase II clinical trial for … company committed to the discovery, development, and commercialization of novel antibody …
-
Couple sues Walgreens and Optum Rx over son's death after $500 price rise for asthma meds
06 Feb 2025 06:07 GMT
… when the story is developing. Whether it' … $500 spike in his asthma medication.
Shanon and William Schmidtknecht, … 39; advance notice of drug price increases.
Pharmacy benefits … health insurance companies, prescription drug companies and pharmacies. Optum …
-
Inhaled Triple Therapy Needs Better Integration into Asthma Care
06 Feb 2025 01:39 GMT
… in implementing it into patients’ treatment regimens.1
“Despite [previous] … Furthermore several treatable traits of asthma, such as, propensity to … ad hoc survey been developed by a panel of … the use of biological drugs.1
Specialists considered persistent …
-
Asthma Care in Winter: Why Inhaler Adherence Matters More Than Ever
05 Feb 2025 15:21 GMT
… is the cornerstone of asthma treatment. By delivering medication directly to the … areas where temperatures fluctuate. Developing a routine is another effective … poses for asthma management and prioritizing treatment adherence, individuals with asthma can …
-
Enveda Expands into Asthma with First-in-Class Lead Asset ENV-294 and Assembles World-Class Advisory Board
05 Feb 2025 14:17 GMT
… potential to redefine asthma treatment by targeting key … A major new asthma drug has not been … trials for novel asthma treatments. He has played a pivotal role in the development … trial design and the development of targeted biologic therapies for asthma …